DrugPatentWatch Database Preview

Plerixafor - Generic Drug Details

« Back to Dashboard

What are the generic sources for plerixafor and what is the scope of plerixafor patent protection?

Plerixafor is the generic ingredient in one branded drug marketed by Genzyme and is included in one NDA. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Plerixafor has forty patent family members in twenty-six countries.

There are seven drug master file entries for plerixafor. One supplier is listed for this compound.

Summary for plerixafor

International Patents:	40
US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	7
Suppliers / Packagers:	1
Bulk Api Vendors:	83
Clinical Trials:	126
Patent Applications:	1,798
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for plerixafor
DailyMed Link:	plerixafor at DailyMed

Pharmacology for plerixafor

Drug Class	Hematopoietic Stem Cell Mobilizer
Physiological Effect	Increased Hematopoietic Stem Cell Mobilization

Synonyms for plerixafor

078P461

1-({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)-1,4,8,11-tetraazacyclotetradecane

1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane

1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane

1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane]

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA)

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA)

1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}

1,1''''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}

1,1'[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane

1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene

1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane

1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane(8HBr.2H2O)

11-{4-[4,8, 11-1,4,8,11tetraaza-cyclotetradec-1-ylmethyl]-benzyl}-1,4,8,11tetraaza-cyclotetradecane-1,4,8-tricarboxylic acid tri-tert-butyl ester

11''''-xylyl bis-1,4,8,11-tetraazacyclotetradecane

110078-46-1

4CA-1029

A25446

A809618

AB0009909

AB01566900_01

AB1008451

AC-26837

AC1L22ET

AJ-81365

AK-41732

AKOS005266706

Amd 3100

AMD-3100

AMD3100

AMD3100 octahydrochloride

AN-436

ANW-73610

AOB5591

AS-42504

BC623053

BCP02337

BCPP000104

BDBM50035696

bicyclam JM-2987

BRD-K33240821-367-01-8

C28H54N8

CHEBI:125354

CHEMBL18442

CS-0451

CTK8C4952

D08971

DB06809

EX-A1762

FT-0660392

GNA & AMD-3100

GTPL844

HHA & AMD-3100

HY-10046

I14-9461

J-503718

JKL 169

JM 2987

JM 3100

JM 3100, AMD3100

JM-3100

JM3100

KS-00000OBY

L000104

LS-187299

MolPort-009-019-417

Mozobil

Mozobil (TN)

NCGC00165722-01

NCGC00165722-02

plerixafor (amd3100)

Plerixafor (JAN/USAN/INN)

Plerixafor [USAN:INN:BAN]

Plerixafor-d4 (deuterated)

Plerixafor(AMD3100)

RL00426

S-7677

s8030

S915P5499N

SC-21932

SCHEMBL19038

SDZ SID 791

SID791

SR-01000941593

SR-01000941593-1

ST2414835

TC-162355

UNII-S915P5499N

YIQPUIGJQJDJOS-UHFFFAOYSA-N

Z2196779619

ZINC22443609

US Patents and Regulatory Information for plerixafor

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Genzyme	MOZOBIL	plerixafor	SOLUTION;SUBCUTANEOUS	022311-001	Dec 15, 2008		RX	Yes	Yes
Genzyme	MOZOBIL	plerixafor	SOLUTION;SUBCUTANEOUS	022311-001	Dec 15, 2008		RX	Yes	Yes

Expired US Patents for plerixafor

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Genzyme	MOZOBIL	plerixafor	SOLUTION;SUBCUTANEOUS	022311-001	Dec 15, 2008
Genzyme	MOZOBIL	plerixafor	SOLUTION;SUBCUTANEOUS	022311-001	Dec 15, 2008

International Patents for plerixafor

Country	Patent Number	Estimated Expiration
Russian Federation	2004105961
Japan	2008195730
China	1561208
European Patent Office	1411918

Supplementary Protection Certificates for plerixafor

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0619813	10C0002	France		PRODUCT NAME: PLERIXAFOR SOUS TOUTES SES FORMES, EN PARTICULIER SES SELS D'ADDITION AVEC UN ACIDE NON TOXIQUE OU SES COMPLEXES AVEC UN METAL; REGISTRATION NO/DATE: EU/1/09/537/001 20090731
1411918	27/2012	Austria		PRODUCT NAME: PLERIXAFOR, GEGEBENENFALLS ALS PHARMAZEUTISCH VERTRAEGLICHES SALZ ODER METALLKOMPLEX DAVON; REGISTRATION NO/DATE: EU/1/09/537/001 20090731
1411918	C300537	Netherlands		PRODUCT NAME: PLERIXAFOR IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VORM; REGISTRATION NO/DATE: EU/1/09/537/001 20090731
1411918	122012000044	Germany		PRODUCT NAME: PLERIXAFOR ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ ODER EIN METALLKOMPLEX DAVON; REGISTRATION NO/DATE: EU/1/09/537/001 20090731